A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Clinical trial NCT04019327 · COMPLETED

Trial details

NCT number: NCT04019327
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Adenocarcinoma Prostate Neoplasm Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2019-07-11
Primary completion: 2025-12-04
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.